Primary Site >> Colorectal Cancer

Gene >> ALK

Journal: Virchows Arch A Pathol Anat Histol. 1981;394(1-2):109-18.
Title: Carcinoplacental alkaline phosphatase in malignant and premalignant conditions of the human digestive tract.
Author: Skinner, J M|Whitehead, R
PMID: 7039085
Journal: Cancer. 1981 Mar 15;47(6):1241-5.
Title: Tumor-associated antigens in polyps and carcinoma of the human large bowel.
Author: Skinner, J M|Whitehead, R
PMID: 6164469
Journal: J Agric Food Chem. 2006 Dec 27;54(26):9792-7.
Title: Wheat bran oil and its fractions inhibit human colon cancer cell growth and intestinal tumorigenesis in Apc(min/+) mice.
Author: Sang, Shengmin|Ju, Jihyeung|Lambert, Joshua D|Lin, Yong|Hong, Jungil|Bose, Mousumi|Wang, Steven|Bai, Naisheng|He, Kan|Reddy, Bandaru S|Ho, Chi-Tang|Li, Frederick|Yang, Chung S
PMID: 17177503
Journal: Asia Pac J Clin Nutr. 2008;17 Suppl 1:249-52.
Title: Anticancer effects of diallyl trisulfide derived from garlic.
Author: Seki, Taiichiro|Hosono, Takashi|Hosono-Fukao, Tomomi|Inada, Kahoru|Tanaka, Rie|Ogihara, Jun|Ariga, Toyohiko
PMID: 18296348
Journal: Carcinogenesis. 2008 Jul;29(7):1400-6.
Title: Alkenyl group is responsible for the disruption of microtubule network formation in human colon cancer cell line HT-29 cells.
Author: Hosono, Takashi|Hosono-Fukao, Tomomi|Inada, Kahoru|Tanaka, Rie|Yamada, Haruhisa|Iitsuka, Yuji|Seki, Taiichiro|Hasegawa, Isao|Ariga, Toyohiko
PMID: 18515280
Journal: Biomacromolecules. 2009 Oct 12;10(10):2839-46.
Title: Low-fouling poly(N-vinyl pyrrolidone) capsules with engineered degradable properties.
Author: Kinnane, Cameron R|Such, Georgina K|Antequera-Garcia, Gema|Yan, Yan|Dodds, Sarah J|Liz-Marzan, Luis M|Caruso, Frank
PMID: 19719165
Journal: Mol Cancer Res. 2009 Sep;7(9):1466-76.
Title: Exon array profiling detects EML4-ALK fusion in breast, colorectal, and non-small cell lung cancers.
Author: Lin, Eva|Li, Li|Guan, Yinghui|Soriano, Robert|Rivers, Celina Sanchez|Mohan, Sankar|Pandita, Ajay|Tang, Jerry|Modrusan, Zora
PMID: 19737969
Journal: Expert Opin Ther Pat. 2010 Dec;20(12):1653-81.
Title: Inhibitors of anaplastic lymphoma kinase: a patent review.
Author: Milkiewicz, Karen L|Ott, Gregory R
PMID: 20961208
Journal: Gastroenterology. 2011 Nov;141(5):1762-72.
Title: Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett's epithelium.
Author: Sato, Toshiro|Stange, Daniel E|Ferrante, Marc|Vries, Robert G J|Van Es, Johan H|Van den Brink, Stieneke|Van Houdt, Winan J|Pronk, Apollo|Van Gorp, Joost|Siersema, Peter D|Clevers, Hans
PMID: 21889923
Journal: Bioorg Med Chem. 2011 Jul 1;19(13):3973-82.
Title: 5-alk(en)ylresorcinols as the major active components in wheat bran inhibit human colon cancer cell growth.
Author: Zhu, Yingdong|Conklin, Dawn R|Chen, Huadong|Wang, Liyan|Sang, Shengmin
PMID: 21658963
Journal: Dtsch Med Wochenschr. 2011 Feb;136(5):179-81.
Title: [Recent results of research on cancer of the colon, gastric cancer, sarcoma and bronchial carcinoma].
Author: Hacker, U T|Wolf, J|Wendtner, C-M
PMID: 21271476
Journal: Mod Pathol. 2011 Mar;24(3):430-42.
Title: Renal cell carcinoma with novel VCL-ALK fusion: new representative of ALK-associated tumor spectrum.
Author: Debelenko, Larisa V|Raimondi, Susana C|Daw, Najat|Shivakumar, Bangalore R|Huang, Dali|Nelson, Marilu|Bridge, Julia A
PMID: 21076462
Journal: Nat Med. 2012 Feb 12;18(3):382-4.
Title: Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies.
Author: Lipson, Doron|Capelletti, Marzia|Yelensky, Roman|Otto, Geoff|Parker, Alex|Jarosz, Mirna|Curran, John A|Balasubramanian, Sohail|Bloom, Troy|Brennan, Kristina W|Donahue, Amy|Downing, Sean R|Frampton, Garrett M|Garcia, Lazaro|Juhn, Frank|Mitchell, Kathy C|Wh
PMID: 22327622
Journal: Oncol Rep. 2012 Oct;28(4):1187-92.
Title: KIF5B/RET fusion gene in surgically-treated adenocarcinoma of the lung.
Author: Yokota, Keisuke|Sasaki, Hidefumi|Okuda, Katsuhiro|Shimizu, Shigeki|Shitara, Masayuki|Hikosaka, Yu|Moriyama, Satoru|Yano, Motoki|Fujii, Yoshitaka
PMID: 22797671
Journal: Expert Rev Mol Diagn. 2012 Jul;12(6):593-602.
Title: Personalized medicine and pharmacogenetic biomarkers: progress in molecular oncology testing.
Author: Ong, Frank S|Das, Kingshuk|Wang, Jay|Vakil, Hana|Kuo, Jane Z|Blackwell, Wendell-Lamar B|Lim, Stephen W|Goodarzi, Mark O|Bernstein, Kenneth E|Rotter, Jerome I|Grody, Wayne W
PMID: 22845480
Journal: Eur J Gastroenterol Hepatol. 2012 Dec;24(12):1430-7.
Title: Colorectal neuroendocrine carcinomas and adenocarcinomas share oncogenic pathways. A clinico-pathologic study of 12 cases.
Author: Karkouche, Raymond|Bachet, Jean-Baptiste|Sandrini, Jeremy|Mitry, Emmanuel|Penna, Christophe|Cote, Jean-Francois|Blons, Helene|Penault-Llorca, Frederique|Rougier, Philippe|Saint Andre, Jean-Paul|Emile, Jean-Francois
PMID: 23114745
Journal: Cell. 2012 Nov 21;151(5):937-50.
Title: MED12 controls the response to multiple cancer drugs through regulation of TGF-beta receptor signaling.
Author: Huang, Sidong|Holzel, Michael|Knijnenburg, Theo|Schlicker, Andreas|Roepman, Paul|McDermott, Ultan|Garnett, Mathew|Grernrum, Wipawadee|Sun, Chong|Prahallad, Anirudh|Groenendijk, Floris H|Mittempergher, Lorenza|Nijkamp, Wouter|Neefjes, Jacques|Salazar, Ramo
PMID: 23178117
Journal: BMC Cancer. 2012 Dec 21;12:612.
Title: Alternative dosing of dual PI3K and MEK inhibition in cancer therapy.
Author: Jokinen, Elina|Laurila, Niina|Koivunen, Jussi P
PMID: 23259591
Journal: ISRN Mol Biol. 2012 May 14;2012:837306.
Title: K-Ras Mutations in Non-Small-Cell Lung Cancer: Prognostic and Predictive Value.
Author: D'Arcangelo, Manolo|Cappuzzo, Federico
PMID: 27398239
Journal: Cancer. 2013 May 1;119(9):1627-35.
Title: Identification of ROS1 rearrangement in gastric adenocarcinoma.
Author: Lee, Jeeyun|Lee, Seung Eun|Kang, So Young|Do, In-Gu|Lee, Sujin|Ha, Sang Yun|Cho, Jeonghee|Kang, Won Ki|Jang, Jiryeon|Ou, Sai-Hong Ignatius|Kim, Kyoung-Mee
PMID: 23400546
Journal: Cancer Genet. 2013 Sep-Oct;206(9-10):330-9.
Title: Low frequency KRAS mutations in colorectal cancer patients and the presence of multiple mutations in oncogenic drivers in non-small cell lung cancer patients.
Author: Jiang, Liyan|Huang, Jiaqi|Morehouse, Chris|Zhu, Wei|Korolevich, Susana|Sui, Dan|Ge, Xiaoxiao|Lehmann, Kim|Liu, Zheng|Kiefer, Christine|Czapiga, Meggan|Su, Xinying|Brohawn, Philip|Gu, Yi|Higgs, Brandon W|Yao, Yihong
PMID: 24200637
Journal: Br J Cancer. 2013 Nov 12;109(10):2735-43.
Title: ALK gene amplification is associated with poor prognosis in colorectal carcinoma.
Author: Bavi, P|Jehan, Z|Bu, R|Prabhakaran, S|Al-Sanea, N|Al-Dayel, F|Al-Assiri, M|Al-Halouly, T|Sairafi, R|Uddin, S|Al-Kuraya, K S
PMID: 24129244
Journal: Eur J Cancer. 2013 Oct;49(15):3076-82.
Title: Feasibility of preemptive biomarker profiling for personalised early clinical drug development at a Comprehensive Cancer Center.
Author: Wiesweg, Marcel|Ting, Saskia|Reis, Henning|Worm, Karl|Kasper, Stefan|Tewes, Mitra|Welt, Anja|Richly, Heike|Meiler, Johannes|Bauer, Sebastian|Hense, Jorg|Gauler, Thomas C|Kohler, Jens|Eberhardt, Wilfried E|Darwiche, Kaid|Freitag, Lutz|Stamatis, Georgios|Br
PMID: 23876834
Journal: Mol Cancer Ther. 2013 May;12(5):777-86.
Title: Crizotinib induces PUMA-dependent apoptosis in colon cancer cells.
Author: Zheng, Xingnan|He, Kan|Zhang, Lin|Yu, Jian
PMID: 23427294
Journal: J Cell Biochem. 2013 Mar;114(3):514-24.
Title: Molecular diagnostics and personalized medicine in oncology: challenges and opportunities.
Author: Normanno, Nicola|Rachiglio, Anna Maria|Roma, Cristin|Fenizia, Francesca|Esposito, Claudia|Pasquale, Raffaella|La Porta, Maria Libera|Iannaccone, Alessia|Micheli, Filippo|Santangelo, Michele|Bergantino, Francesca|Costantini, Susan|De Luca, Antonella
PMID: 22991232
Journal: Clin Chem. 2013 Oct;59(10):1447-56.
Title: Companion biomarkers: paving the pathway to personalized treatment for cancer.
Author: Duffy, Michael J|Crown, John
PMID: 23656699
Journal:
Title:
Author: Meleth, Sreelatha|Reeder-Hayes, Katherine|Ashok, Mahima|Clark, Robert|Funkhouser, William|Wines, Roberta|Hill, Christine|Shanahan, Ellen|McClure, Emily|Burson, Katrina|Coker-Schwimmer, Manny|Garge, Nikhil|Jonas, Daniel E
PMID: 25905152
Journal: Cancer Epidemiol Biomarkers Prev. 2014 Dec;23(12):2965-70.
Title: Programmed cell death 1 (PD-1) and its ligand (PD-L1) in common cancers and their correlation with molecular cancer type.
Author: Gatalica, Zoran|Snyder, Carrie|Maney, Todd|Ghazalpour, Anatole|Holterman, Daniel A|Xiao, Nianqing|Overberg, Peggy|Rose, Inga|Basu, Gargi D|Vranic, Semir|Lynch, Henry T|Von Hoff, Daniel D|Hamid, Omid
PMID: 25392179
Journal: Acta Neuropathol. 2014 Dec;128(6):879-91.
Title: Predictive molecular markers in metastases to the central nervous system: recent advances and future avenues.
Author: Berghoff, Anna Sophie|Bartsch, Rupert|Wohrer, Adelheid|Streubel, Berthold|Birner, Peter|Kros, Johan M|Brastianos, Priscilla K|von Deimling, Andreas|Preusser, Matthias
PMID: 25287912
Journal: Ann Surg Oncol. 2014 Aug;21(8):2642-9.
Title: The frequencies and clinical implications of mutations in 33 kinase-related genes in locally advanced rectal cancer: a pilot study.
Author: Abdul-Jalil, Khairun I|Sheehan, Katherine M|Toomey, Sinead|Schmid, Jasmin|Prehn, Jochen|O'Grady, Anthony|Cummins, Robert|O'Neill, Brian|McNamara, Deborah A|Deasy, Joseph|Breathnach, Oscar|Grogan, Liam|Rogers, Ailin|Doherty, Glen|Winter, Des|Ryan, John|El-
PMID: 24700299
Journal: PLoS One. 2014 Apr 1;9(4):e92147.
Title: Gain of ALK gene copy number may predict lack of benefit from anti-EGFR treatment in patients with advanced colorectal cancer and RAS-RAF-PI3KCA wild-type status.
Author: Pietrantonio, Filippo|Maggi, Claudia|Di Bartolomeo, Maria|Facciorusso, Maria Grazia|Perrone, Federica|Testi, Adele|Iacovelli, Roberto|Miceli, Rosalba|Bossi, Ilaria|Leone, Giorgia|Milione, Massimo|Pelosi, Giuseppe|de Braud, Filippo
PMID: 24691006
Journal: Mol Cancer Res. 2014 Jan;12(1):111-8.
Title: ROS1 and ALK fusions in colorectal cancer, with evidence of intratumoral heterogeneity for molecular drivers.
Author: Aisner, Dara L|Nguyen, Teresa T|Paskulin, Diego D|Le, Anh T|Haney, Jerry|Schulte, Nathan|Chionh, Fiona|Hardingham, Jenny|Mariadason, John|Tebbutt, Niall|Doebele, Robert C|Weickhardt, Andrew J|Varella-Garcia, Marileila
PMID: 24296758
Journal: J Oncol Pharm Pract. 2014 Feb;20(1):11-28.
Title: Predictive and prognostic biomarkers with therapeutic targets in breast, colorectal, and non-small cell lung cancers: a systemic review of current development, evidence, and recommendation.
Author: Chung, Clement|Christianson, Matthew
PMID: 23493335
Journal: Rinsho Byori. 2015 Nov;63(11):1310-5.
Title: [Companion Diagnostics for Solid Tumors].
Author: Watanabe, Atsushi
PMID: 26995877
Journal: Medicine (Baltimore). 2015 Dec;94(51):e2342.
Title: Incomplete Intestinal Obstruction Caused by a Rare Epithelioid Inflammatory Myofibroblastic Sarcoma of the Colon: A Case Report.
Author: Bai, Yanjun|Jiang, Maofen|Liang, Wenjie|Chen, Feng
PMID: 26705227
Journal: Biomed Rep. 2015 Jan;3(1):9-13.
Title: Molecular characterization of WDCP, a novel fusion partner for the anaplastic lymphoma tyrosine kinase ALK.
Author: Yokoyama, Noriko|Miller, W Todd
PMID: 25469238
Journal: PLoS One. 2015 Dec 17;10(12):e0144731.
Title: Anaplastic Lymphoma Kinase Rearrangement in Digestive Tract Cancer: Implication for Targeted Therapy in Chinese Population.
Author: Ying, Jianming|Lin, Chen|Wu, Jian|Guo, Lei|Qiu, Tian|Ling, Yun|Shan, Ling|Zhou, Haitao|Zhao, Dongbing|Wang, Jian|Liang, Jianwei|Zhao, Jianjun|Jiao, Yuchen|Lu, Ning|Zhao, Hong
PMID: 26678488
Journal: Clin Epigenetics. 2015 Dec 16;7:129.
Title: MicroRNA profiling of primary pulmonary enteric adenocarcinoma in members from the same family reveals some similarities to pancreatic adenocarcinoma-a step towards personalized therapy.
Author: Garajova, Ingrid|Funel, Niccola|Fiorentino, Michelangelo|Agostini, Valentina|Ferracin, Manuela|Negrini, Massimo|Frassineti, Giovanni Luca|Gavelli, Giampaolo|Frampton, Adam Enver|Biasco, Guido|Giovannetti, Elisa
PMID: 26677401
Journal: Br J Cancer. 2015 Dec 22;113(12):1730-4.
Title: Novel CAD-ALK gene rearrangement is drugable by entrectinib in colorectal cancer.
Author: Amatu, Alessio|Somaschini, Alessio|Cerea, Giulio|Bosotti, Roberta|Valtorta, Emanuele|Buonandi, Pasquale|Marrapese, Giovanna|Veronese, Silvio|Luo, David|Hornby, Zachary|Multani, Pratik|Murphy, Danielle|Shoemaker, Robert|Lauricella, Calogero|Giannetta, Laur
PMID: 26633560
Journal: Hum Pathol. 2015 Dec;46(12):1956-61.
Title: Epstein-Barr virus-associated inflammatory pseudotumor presenting as a colonic mass.
Author: Gong, Shunyou|Auer, Iwona|Duggal, Rajan|Pittaluga, Stefania|Raffeld, Mark|Jaffe, Elaine S
PMID: 26477709
Journal: World J Clin Oncol. 2015 Oct 10;6(5):104-8.
Title: Current and future treatment of anaplastic lymphoma kinase-rearranged cancer.
Author: Mologni, Luca
PMID: 26468446
Journal: Cancer Gene Ther. 2015 Sep;22(9):417-30.
Title: A 2015 update on predictive molecular pathology and its role in targeted cancer therapy: a review focussing on clinical relevance.
Author: Dietel, M|Johrens, K|Laffert, M V|Hummel, M|Blaker, H|Pfitzner, B M|Lehmann, A|Denkert, C|Darb-Esfahani, S|Lenze, D|Heppner, F L|Koch, A|Sers, C|Klauschen, F|Anagnostopoulos, I
PMID: 26358176
Journal: Oncotarget. 2015 Sep 15;6(27):24320-32.
Title: Detection of novel and potentially actionable anaplastic lymphoma kinase (ALK) rearrangement in colorectal adenocarcinoma by immunohistochemistry screening.
Author: Lee, Jeeyun|Kim, Hee Cheol|Hong, Jung Yong|Wang, Kai|Kim, Sun Young|Jang, Jiryeon|Kim, Seung Tae|Park, Joon Oh|Lim, Ho Yeong|Kang, Won Ki|Park, Young Suk|Lee, Jiyun|Lee, Woo Yong|Park, Yoon Ah|Huh, Jung Wook|Yun, Seong Hyeon|Do, In-Gu|Kim, Seok Hyung|Bala
PMID: 26172300
Journal: Nat Commun. 2015 Apr 30;6:7002.
Title: The molecular landscape of colorectal cancer cell lines unveils clinically actionable kinase targets.
Author: Medico, Enzo|Russo, Mariangela|Picco, Gabriele|Cancelliere, Carlotta|Valtorta, Emanuele|Corti, Giorgio|Buscarino, Michela|Isella, Claudio|Lamba, Simona|Martinoglio, Barbara|Veronese, Silvio|Siena, Salvatore|Sartore-Bianchi, Andrea|Beccuti, Marco|Mottolese
PMID: 25926053
Journal: Ther Adv Med Oncol. 2015 Mar;7(2):56-62.
Title: Anaplastic lymphoma kinase (ALK) gene alteration in signet ring cell carcinoma of the gastrointestinal tract.
Author: Alese, Olatunji B|El-Rayes, Bassel F|Sica, Gabriel|Zhang, Guojing|Alexis, Dianne|La Rosa, Francisco G|Varella-Garcia, Marileila|Chen, Zhengjia|Rossi, Michael R|Adsay, Nazim V|Khuri, Fadlo R|Owonikoko, Taofeek K
PMID: 25755678
Journal: Metabolism. 2015 Mar;64(3 Suppl 1):S16-21.
Title: Biomarkers for personalized oncology: recent advances and future challenges.
Author: Kalia, Madhu
PMID: 25468140
Journal: Appl Immunohistochem Mol Morphol. 2015 Feb;23(2):134-8.
Title: ALK and ROS1 overexpression is very rare in colorectal adenocarcinoma.
Author: Houang, Michelle|Toon, Christopher W|Clarkson, Adele|Sioson, Loretta|de Silva, Keshani|Watson, Nicole|Singh, Nisha R|Chou, Angela|Gill, Anthony J
PMID: 24992173
Journal: Expert Opin Investig Drugs. 2015;24(11):1493-500.
Title: Entrectinib: a potent new TRK, ROS1, and ALK inhibitor.
Author: Rolfo, Christian|Ruiz, Rossana|Giovannetti, Elisa|Gil-Bazo, Ignacio|Russo, Antonio|Passiglia, Francesco|Giallombardo, Marco|Peeters, Marc|Raez, Luis
PMID: 26457764
Journal: Tumori. 2016 Dec 1;102(6):541-547.
Title: How the lab is changing our view of colorectal cancer.
Author: Cremolini, Chiara|Pietrantonio, Filippo
PMID: 27647226
Journal: Cancer Discov. 2016 Sep;6(9):963-71.
Title: MET-Driven Resistance to Dual EGFR and BRAF Blockade May Be Overcome by Switching from EGFR to MET Inhibition in BRAF-Mutated Colorectal Cancer.
Author: Pietrantonio, Filippo|Oddo, Daniele|Gloghini, Annunziata|Valtorta, Emanuele|Berenato, Rosa|Barault, Ludovic|Caporale, Marta|Busico, Adele|Morano, Federica|Gualeni, Ambra Vittoria|Alessi, Alessandra|Siravegna, Giulia|Perrone, Federica|Di Bartolomeo, Maria|
PMID: 27325282
Journal: Gastroenterology. 2016 Aug;151(2):278-287.e6.
Title: Genomic Alterations Observed in Colitis-Associated Cancers Are Distinct From Those Found in Sporadic Colorectal Cancers and Vary by Type of Inflammatory Bowel Disease.
Author: Yaeger, Rona|Shah, Manish A|Miller, Vincent A|Kelsen, Judith R|Wang, Kai|Heins, Zachary J|Ross, Jeffrey S|He, Yuting|Sanford, Eric|Yantiss, Rhonda K|Balasubramanian, Sohail|Stephens, Philip J|Schultz, Nikolaus|Oren, Moshe|Tang, Laura|Kelsen, David
PMID: 27063727
Journal: Mol Cancer Ther. 2016 Apr;15(4):628-39.
Title: Entrectinib, a Pan-TRK, ROS1, and ALK Inhibitor with Activity in Multiple Molecularly Defined Cancer Indications.
Author: Ardini, Elena|Menichincheri, Maria|Banfi, Patrizia|Bosotti, Roberta|De Ponti, Cristina|Pulci, Romana|Ballinari, Dario|Ciomei, Marina|Texido, Gemma|Degrassi, Anna|Avanzi, Nilla|Amboldi, Nadia|Saccardo, Maria Beatrice|Casero, Daniele|Orsini, Paolo|Bandiera,
PMID: 26939704
Journal: Oncol Lett. 2016 Feb;11(2):1493-1495.
Title: Diffuse large B-cell lymphoma in colon confounded by prior history of colorectal cancer: A case report and literature review.
Author: Ren, Yanling|Chen, Zhilu|Su, Chuanyong|Tong, Hongyan|Qian, Wenbin
PMID: 26893766
Journal: J Clin Pathol. 2016 Sep;69(9):767-71.
Title: Less frequently mutated genes in colorectal cancer: evidences from next-generation sequencing of 653 routine cases.
Author: Malapelle, Umberto|Pisapia, Pasquale|Sgariglia, Roberta|Vigliar, Elena|Biglietto, Maria|Carlomagno, Chiara|Giuffre, Giuseppe|Bellevicine, Claudio|Troncone, Giancarlo
PMID: 26797410
Journal: Curr Med Chem. 2016;23(2):142-60.
Title: ROS1 Kinase Inhibitors for Molecular-Targeted Therapies.
Author: Al-Sanea, M M|Abdelazem, A Z|Park, B S|Yoo, K H|Sim, T|Kwon, Y J|Lee, S H
PMID: 26438251
Journal: Clin Cancer Res. 2016 Aug 1;22(15):3831-40.
Title: Oncogenic ALK Fusion in Rare and Aggressive Subtype of Colorectal Adenocarcinoma as a Potential Therapeutic Target.
Author: Yakirevich, Evgeny|Resnick, Murray B|Mangray, Shamlal|Wheeler, Michael|Jackson, Cynthia L|Lombardo, Kara A|Lee, Jeeyun|Kim, Kyoung-Mee|Gill, Anthony J|Wang, Kai|Gowen, Kyle|Sun, James|Miller, Vincent A|Stephens, Philip J|Ali, Siraj M|Ross, Jeffrey S|Safra
PMID: 26933125
Journal: Genes Chromosomes Cancer. 2017 Nov;56(11):769-787.
Title: The co-regulatory networks of tumor suppressor genes, oncogenes, and miRNAs in colorectal cancer.
Author: Slattery, Martha L|Herrick, Jennifer S|Mullany, Lila E|Samowitz, Wade S|Sevens, John R|Sakoda, Lori|Wolff, Roger K
PMID: 28675510
Journal: J Natl Cancer Inst. 2017 Dec 1;109(12). pii: 3860155.
Title: ALK, ROS1, and NTRK Rearrangements in Metastatic Colorectal Cancer.
Author: Pietrantonio, Filippo|Di Nicolantonio, Federica|Schrock, Alexa B|Lee, Jeeyun|Tejpar, Sabine|Sartore-Bianchi, Andrea|Hechtman, Jaclyn F|Christiansen, Jason|Novara, Luca|Tebbutt, Niall|Fuca, Giovanni|Antoniotti, Carlotta|Kim, Seung Tae|Murphy, Danielle|Bere
PMID: 29370427
Journal: Cancer Med. 2017 Dec;6(12):2972-2983.
Title: In vivo imaging xenograft models for the evaluation of anti-brain tumor efficacy of targeted drugs.
Author: Kita, Kenji|Arai, Sachiko|Nishiyama, Akihiro|Taniguchi, Hirokazu|Fukuda, Koji|Wang, Rong|Yamada, Tadaaki|Takeuchi, Shinji|Tange, Shoichiro|Tajima, Atsushi|Nakada, Mitsutoshi|Yasumoto, Kazuo|Motoo, Yoshiharu|Murakami, Takashi|Yano, Seiji
PMID: 29125233
Journal: Oncotarget. 2017 Jul 24;8(33):55353-55360.
Title: Identification and characterization of a novel SCYL3-NTRK1 rearrangement in a colorectal cancer patient.
Author: Milione, Massimo|Ardini, Elena|Christiansen, Jason|Valtorta, Emanuele|Veronese, Silvio|Bosotti, Roberta|Pellegrinelli, Alessio|Testi, Adele|Pietrantonio, Filippo|Fuca, Giovanni|Wei, Ge|Murphy, Danielle|Siena, Salvatore|Isacchi, Antonella|De Braud, Filippo
PMID: 28903424
Journal: Oncologist. 2017 Jul;22(7):774-779.
Title: Detection of an ALK Fusion in Colorectal Carcinoma by Hybrid Capture-Based Assay of Circulating Tumor DNA.
Author: Lai, Andrea Z|Schrock, Alexa B|Erlich, Rachel L|Ross, Jeffrey S|Miller, Vincent A|Yakirevich, Evgeny|Ali, Siraj M|Braiteh, Fadi
PMID: 28507204
Journal: Pharmacol Res. 2017 Jul;121:202-212.
Title: ROS1 protein-tyrosine kinase inhibitors in the treatment of ROS1 fusion protein-driven non-small cell lung cancers.
Author: Roskoski, Robert Jr
PMID: 28465216
Journal: Ann Oncol. 2017 Jun 1;28(6):1302-1308.
Title: Tracking a CAD-ALK gene rearrangement in urine and blood of a colorectal cancer patient treated with an ALK inhibitor.
Author: Siravegna, G|Sartore-Bianchi, A|Mussolin, B|Cassingena, A|Amatu, A|Novara, L|Buscarino, M|Corti, G|Crisafulli, G|Bartolini, A|Tosi, F|Erlander, M|Di Nicolantonio, F|Siena, S|Bardelli, A
PMID: 28368455
Journal: Cancer Discov. 2017 Apr;7(4):400-409.
Title: Safety and Antitumor Activity of the Multitargeted Pan-TRK, ROS1, and ALK Inhibitor Entrectinib: Combined Results from Two Phase I Trials (ALKA-372-001 and STARTRK-1).
Author: Drilon, Alexander|Siena, Salvatore|Ou, Sai-Hong Ignatius|Patel, Manish|Ahn, Myung Ju|Lee, Jeeyun|Bauer, Todd M|Farago, Anna F|Wheler, Jennifer J|Liu, Stephen V|Doebele, Robert|Giannetta, Laura|Cerea, Giulio|Marrapese, Giovanna|Schirru, Michele|Amatu, Ales
PMID: 28183697
Journal: J Oncol Pract. 2017 Mar;13(3):e185-e196.
Title: Medical Oncologists' Experiences in Using Genomic Testing for Lung and Colorectal Cancer Care.
Author: Gray, Stacy W|Kim, Benjamin|Sholl, Lynette|Cronin, Angel|Parikh, Aparna R|Klabunde, Carrie N|Kahn, Katherine L|Haggstrom, David A|Keating, Nancy L
PMID: 28095174
Journal: Am J Hematol. 2018 May;93(5):607-614.
Title: Long-term effects of crizotinib in ALK-positive tumors (excluding NSCLC): A phase 1b open-label study.
Author: Gambacorti-Passerini, Carlo|Orlov, Sergey|Zhang, Li|Braiteh, Fadi|Huang, Huiqiang|Esaki, Taito|Horibe, Keizo|Ahn, Jin-Seok|Beck, Joseph T|Edenfield, William Jeffrey|Shi, Yuankai|Taylor, Matthew|Tamura, Kenji|Van Tine, Brian A|Wu, Shang-Ju|Paolini, Jolanda
PMID: 29352732
Journal: Oncotarget. 2018 Feb 16;9(18):14306-14310.
Title: TP53 mutations and number of alterations correlate with maximum standardized uptake value (SUVmax) determined by positron emission tomography/computed tomography (PET/CT) [(18)F] fluorodeoxyglucose ((18)F-FDG PET).
Author: Chang, Geraldine H|Kurzrock, Razelle|Tran, Lisa|Schwaederle, Maria|Hoh, Carl K
PMID: 29581845
Journal: Clin Cancer Res. 2018 Aug 1;24(15):3550-3559.
Title: Exome Sequencing of Plasma DNA Portrays the Mutation Landscape of Colorectal Cancer and Discovers Mutated VEGFR2 Receptors as Modulators of Antiangiogenic Therapies.
Author: Toledo, Rodrigo A|Garralda, Elena|Mitsi, Maria|Pons, Tirso|Monsech, Jorge|Vega, Estela|Otero, Alvaro|Albarran, Maria I|Banos, Natalia|Duran, Yolanda|Bonilla, Victoria|Sarno, Francesca|Camacho-Artacho, Marta|Sanchez-Perez, Tania|Perea, Sofia|Alvarez, Rafae
PMID: 29588308
Journal: Oncotarget. 2018 May 8;9(35):23960-23974.
Title: Identification of different mutational profiles in cancers arising in specific colon segments by next generation sequencing.
Author: Oliveira, Duarte Mendes|Laudanna, Carmelo|Migliozzi, Simona|Zoppoli, Pietro|Santamaria, Gianluca|Grillone, Katia|Elia, Laura|Mignogna, Chiara|Biamonte, Flavia|Sacco, Rosario|Corcione, Francesco|Viglietto, Giuseppe|Malanga, Donatella|Rizzuto, Antonia
PMID: 29844865
Journal: Br J Cancer. 2018 Jul;119(2):230-240.
Title: Integrative analysis of oncogenic fusion genes and their functional impact in colorectal cancer.
Author: Choi, Yuri|Kwon, Chae Hwa|Lee, Seon Jin|Park, Joonghoon|Shin, Jong-Yeon|Park, Do Youn
PMID: 29955133